Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albany Molecular Research (AMRI) has entered into an agreement with Proteros Biostructures to jointly offer drug discovery and protein crystallization/x-ray structural analysis services to biotechnology and pharmaceutical companies.
Subscribe to our email newsletter
Under the agreement, AMRI will combine its discovery and development capabilities with Proteros’ structural biology services to offer better services to the life sciences industry worldwide.
Proteros is a provider of protein crystallization and X-ray structural analysis services, while AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for healthcare companies.
Proteros CEO Torsten Neuefeind said he looks forward to the new opportunities they can provide to the life science community as a result of this alliance with AMRI.